ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,311.59
0.07%
Dow Jones
39,851.99
0.11%
US Dollar vs MXN
16.5821
0.16%
Brent Oil
82.57
-1.15%
Bitcoin
70,054.72
-1.95%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. DelMar Pharmaceuticals Inc (DMPI)

  7. DelMar Pharmaceuticals Inc (DMPI) Noticias

DMPI

DelMar Pharmaceuticals (DMPI)

DelMar Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DMPI
FechaHoraFuenteTítuloSímboloCompañía
15/06/202314:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMPIDelMar Pharmaceuticals Inc
11/05/202307:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DMPIDelMar Pharmaceuticals Inc
31/03/202315:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DMPIDelMar Pharmaceuticals Inc
31/03/202315:15Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DMPIDelMar Pharmaceuticals Inc
13/02/202315:30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DMPIDelMar Pharmaceuticals Inc
27/09/202215:37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DMPIDelMar Pharmaceuticals Inc
27/09/202207:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DMPIDelMar Pharmaceuticals Inc
03/08/202215:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMPIDelMar Pharmaceuticals Inc
03/08/202208:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:DMPIDelMar Pharmaceuticals Inc
06/05/202215:12Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DMPIDelMar Pharmaceuticals Inc
26/04/202215:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:DMPIDelMar Pharmaceuticals Inc
03/05/202115:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DMPIDelMar Pharmaceuticals Inc
02/04/202105:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DMPIDelMar Pharmaceuticals Inc
24/03/202116:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:DMPIDelMar Pharmaceuticals Inc
16/11/202013:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DMPIDelMar Pharmaceuticals Inc
04/11/202015:45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:DMPIDelMar Pharmaceuticals Inc
24/09/202018:29Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:DMPIDelMar Pharmaceuticals Inc
28/08/202009:50Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:DMPIDelMar Pharmaceuticals Inc
18/08/202007:30PR Newswire (US)DelMar Announces $19.6 Million Private Placement Priced At-The-MarketNASDAQ:DMPIDelMar Pharmaceuticals Inc
17/08/202007:30PR Newswire (US)DelMar Announces Approval of Merger by StockholdersNASDAQ:DMPIDelMar Pharmaceuticals Inc
17/07/202007:00PR Newswire (US)DelMar Pharmaceuticals to Host Conference Call to Discuss Proposed Acquisition of Adgero PharmaceuticalsNASDAQ:DMPIDelMar Pharmaceuticals Inc
02/07/202016:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DMPIDelMar Pharmaceuticals Inc
24/06/202007:30PR Newswire (US)DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Resear...NASDAQ:DMPIDelMar Pharmaceuticals Inc
22/06/202007:30PR Newswire (US)DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed an...NASDAQ:DMPIDelMar Pharmaceuticals Inc
16/06/202016:12Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:DMPIDelMar Pharmaceuticals Inc
10/06/202007:30PR Newswire (US)DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology PipelineNASDAQ:DMPIDelMar Pharmaceuticals Inc
04/06/202007:00PR Newswire (US)Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals' VAL-083 to Participate in the GBM AGILE Pivotal...NASDAQ:DMPIDelMar Pharmaceuticals Inc
01/06/202007:00PR Newswire (US)DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Canc...NASDAQ:DMPIDelMar Pharmaceuticals Inc
13/05/202007:00PR Newswire (US)DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate UpdatesNASDAQ:DMPIDelMar Pharmaceuticals Inc
05/05/202007:00PR Newswire (US)DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment o...NASDAQ:DMPIDelMar Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:DMPI

Su Consulta Reciente

USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
CCOM
SILVER
SILVER
USI
USTECH100
US Tech 100
NASDAQ
MSFT
Microsoft
NYSE
MCD
McDonalds
NASDAQ
GOOGL
Alphabet
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US500
US 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AAPL
Apple
NYSE
AXP
American Express
AMEX
XLF
Financial Select Sector
COIN
SOLUSD
Solana
NYSE
CVX
Chevron
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados